FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series D or later / Biotech startups that raised Series D or later in Shanghai, China

Biotech startups that raised Series D or later in Shanghai, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series D or later in Shanghai, China
One-time CSV
  • 20 funded companies, 15 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-d-plus~shanghai-shanghai.csv20 rows × 18 columns
CompanyCityLast roundAmountDate
Drug FarmShanghaiSeries D$55.0M2026-07-13
Full-Life TechnologiesShanghaiSeries D$109.0M2026-05-18
CORXEL PharmaceuticalsShanghaiSeries D$287.0M2026-01-22
Shende Medical Equipment TechnologyShanghaiSeries D$27.4M2023-10-10

4 rows of the CSV in 5 of its 18 columns.

20
Startups
$2.0B
Total raised
4
Funded in the last 12 months
$487.9M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

3 of 20
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Drug Farm Drug Farm develops therapies for infectious, immunological, and inflammatory diseases using genetics and artificial intelligence. Artificial intelligence Series D $55.0M 2026-07-13 $138.0M DT Capital Partners, South China Venture Capital, BVCF +1 101 to 250 2015
Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019

Table 1. Biotech startups that raised Series D or later in Shanghai, China: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019
2 Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
3 Drug Farm Drug Farm develops therapies for infectious, immunological, and inflammatory diseases using genetics and artificial intelligence. Artificial intelligence Series D $55.0M 2026-07-13 $138.0M DT Capital Partners, South China Venture Capital, BVCF +1 101 to 250 2015

Table 2. Biotech startups that raised Series D or later in Shanghai, China: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 South China Venture Capital Private equity firm Shenzhen, China 1 5% 1 Drug Farm
2 YD Capital Private equity firm Prague, Czech Republic 1 5% 1 Drug Farm
3 BVCF Private equity firm Shanghai, China 1 5% 1 Drug Farm
4 DT Capital Partners Private equity firm Shanghai, China 1 5% 1 Drug Farm
5 Summer Capital Private equity firm Hong Kong 1 5% 1 Full-Life Technologies
6 Sky9 Capital Venture capital firm 1 5% 1 Full-Life Technologies
7 Chengwei Capital Venture capital firm Shanghai, China 1 5% 1 Full-Life Technologies
8 Prosperity7 Ventures Venture capital firm Dhahran, Saudi Arabia 1 5% 1 Full-Life Technologies
9 Leaps by Bayer Corporate venture arm Leverkusen, Germany 1 5% 1 CORXEL Pharmaceuticals
10 RTW Investments Hedge fund New York, United States 1 5% 1 CORXEL Pharmaceuticals
11 Jianxin Capital Venture capital firm Shanghai, China 1 5%
12 Chongqing Venture Capital Venture capital firm Chongqing, China 1 5%
13 Sinowisdom Venture capital firm Hangzhou, China 1 5%
14 Zuig Investment Private equity firm Hangzhou, China 1 5%
15 Jianmu Investment Fund of funds Minhang, China 1 5%

Table 3. Biotech startups that raised Series D or later in Shanghai, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 17 85% $1.7B
Artificial intelligence 2 10% $138.0M
Software 2 10% $138.0M

Table 4. Biotech startups that raised Series D or later in Shanghai, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series D+ 20 100% $86.2M

Table 5. Biotech startups that raised Series D or later in Shanghai, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
July 2026 2 50% $91.9M
May 2026 1 25% $109.0M
January 2026 1 25% $287.0M

Table 6. Biotech startups that raised Series D or later in Shanghai, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 20% $487.9M
2025 3 15% $82.4M
2023 1 5% $27.4M
2022 4 20% $226.0M
2021 2 10% $105.0M
2020 4 20% $519.7M

Table 7. Biotech startups that raised Series D or later in Shanghai, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 1 5%
2015 to 2019 8 40%
2010 to 2014 8 40%
Before 2010 3 15%

Table 8. Biotech startups that raised Series D or later in Shanghai, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
11 to 50 5 25%
51 to 100 5 25%
101 to 250 3 15%
251 to 500 3 15%
501 to 1,000 2 10%
1,001 to 5,000 1 5%
5,001 to 10,000 1 5%

Table 9. Biotech startups that raised Series D or later in Shanghai, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Shanghai, China whose last round is Series D or later are on the list?
20, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series D or later in Shanghai, China: 20 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Shanghai

Other sectors that raised Series D or later in Shanghai

Cite: FundingWatcher, 20 biotech companies in Shanghai, China whose most recent round is Series D or later, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-d-plus/shanghai-shanghai/